Coronavirus vaccine trial resumes after week-long pause
Some of the vaccine trials in the United States are taking place at Indiana University School of Medicine in Indianapolis.
Medical Research
Articles
IU cancer center researchers land $5.7M grant to study chemo-induced side effects
The grant will help fund an ongoing study to evaluate long-term health outcomes for cancer patients who receive life-saving chemotherapy treatments that often have difficult side effects.
Lilly, IU School of Medicine team up on $5M immunology research pact
Under the agreement, researchers will study patients who used Lilly autoimmune therapies that are under consideration for the treatment of other autoimmune diseases, including inflammatory bowel disease and psoriasis.
After years of turmoil, biotech testing firm aims to grow again
West Lafayette-based Bioanalytical Systems’ latest executive departure comes amid recent signs of stability, turnaround and growth for a company that just three years ago was on the verge of sinking.
Motorsports research body hires new director, relocating to Indianapolis
The International Council of Motorsport Sciences, established in Indianapolis in 1988, will relocate from Texas later this month after hiring veteran motorsports exec Tom Weisenbach as its new executive director.
Q&A: Elaine Bedel on raising money for women-led research
Development Corp., is helping raise money for a women-focused cancer research initiative. The campaign, which will run through June, is in its second year.
2020 Innovation Issue: Brothers share a knack for creating life sciences companies
Philip and Martin Low’s latest venture, Eradivir, was incorporated in February to develop a treatment that would fight the influenza virus, but COVID-19 prompted a tweak to the business plan.
2020 Innovation Issue: Bias is often baked into research, development
For companies that pursue technological advances and innovative solutions, bias can have an enduring impact, making it easy for the cycle to be perpetuated.
2020 Innovation Issue: Pushing hard for a COVID-19 vaccine
Around the world, more than 80 vaccine projects are under development by pharmaceutical companies and university research laboratories.
2020 Innovation Issue: Regenstrief’s half century of health innovations
The not-for-profit and its health research are a testament to the idea that all innovation is related—even when the connection appears tenuous at first glance.
IU team pursuing breathtaking advancements in regenerative medicine
The emerging health care field seeks to develop methods for replacing or reinvigorating damaged human organs, cells and tissues.
Researchers scour COVID-19 data to find peak
Health-data specialists at universities and research institutes in Indianapolis expect the virus to hit its peak between mid-April and early May, packing a punch that could cause about 800 new positive COVID-19 cases a day.
Lilly teams with Canadian biotech in race to find treatment for COVID-19
The Indianapolis-based drugmaker said it will combine its capability for quickly developing antibodies with AbCellera’s “rapid pandemic response platform,” with the goal of getting a treatment into clinics for human testing within four months.
Butler researchers point to way to stop deadly coronavirus from spreading
Dr. Christopher Stobart and his students are focusing on an enzyme in the virus that could inhibit its replication, and plan to submit the findings to a virology journal in coming months.
Ravi Parikh: Why for-profit research should be taken seriously
Patient data is increasingly in the hands of for-profit industries. Insurance firms and other for-profit companies have been collecting patient data that yields important information that could be used to shape medical care and health policy.
New scientific study reveals more about the power of snot
Mucus may be gross, but we produce a lot of it. And new research is uncovering just how beneficial it is in the human body.
Cook Regentec spins off first biotech from Indy-based incubator
The spinoff, called Sexton Biotechnologies, has raised $5 million in outside investment and will spin off in October. The biotech develops cell and gene therapy tools used to grow cells for medical purposes.
App’s success leads Don Brown to embrace consumer market
After building and selling three companies and starting a fourth, Dr. Don Brown thought he had seen it all. Even so, he still gets an occasional surprise.
Startup claims breakthrough in gauging pain
MindX founders think they’ve found a scientific way to measure pain and other hard-to-quantify mental health conditions, such as suicide risk, depression and post-traumatic stress disorder.
IBJ Podcast: This IU pediatrician is a health care myth buster
Should you avoid red meat? No. Should you strive for 10,000 steps a day? Not unless you just want to. So says Dr. Aaron Carroll, a pediatrician and researcher at the Indiana University School of Medicine who sees it as his life’s calling to debunk what he considers health myths and weak medical research.